BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

757 related articles for article (PubMed ID: 23057504)

  • 1. Obstructing toxin pathways by targeted pore blockage.
    Nestorovich EM; Bezrukov SM
    Chem Rev; 2012 Dec; 112(12):6388-430. PubMed ID: 23057504
    [No Abstract]   [Full Text] [Related]  

  • 2. Pore-forming toxins.
    Gilbert RJ
    Cell Mol Life Sci; 2002 May; 59(5):832-44. PubMed ID: 12088283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibiting bacterial toxins by channel blockage.
    Bezrukov SM; Nestorovich EM
    Pathog Dis; 2016 Mar; 74(2):. PubMed ID: 26656888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insertion and organization within membranes of the delta-endotoxin pore-forming domain, helix 4-loop-helix 5, and inhibition of its activity by a mutant helix 4 peptide.
    Gerber D; Shai Y
    J Biol Chem; 2000 Aug; 275(31):23602-7. PubMed ID: 10811807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular features of the cytolytic pore-forming bacterial protein toxins.
    Alouf JE
    Folia Microbiol (Praha); 2003; 48(1):5-16. PubMed ID: 12744072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Voltage gating is a fundamental feature of porin and toxin beta-barrel membrane channels.
    Bainbridge G; Gokce I; Lakey JH
    FEBS Lett; 1998 Jul; 431(3):305-8. PubMed ID: 9714531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteins: membrane binding and pore formation. Preface.
    Anderluh G; Lakey J
    Adv Exp Med Biol; 2010; 677():v-vi. PubMed ID: 20687475
    [No Abstract]   [Full Text] [Related]  

  • 8. Structural Basis of the Pore-Forming Toxin/Membrane Interaction.
    Li Y; Li Y; Mengist HM; Shi C; Zhang C; Wang B; Li T; Huang Y; Xu Y; Jin T
    Toxins (Basel); 2021 Feb; 13(2):. PubMed ID: 33572271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adaptation of a conjugal transfer system for the export of pathogenic macromolecules.
    Winans SC; Burns DL; Christie PJ
    Trends Microbiol; 1996 Feb; 4(2):64-8. PubMed ID: 8820569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A dominant-negative therapy for anthrax.
    Leppla SH
    Nat Med; 2001 Jun; 7(6):659-60. PubMed ID: 11385497
    [No Abstract]   [Full Text] [Related]  

  • 11. Bacterial protein toxins and lipids: pore formation or toxin entry into cells.
    Geny B; Popoff MR
    Biol Cell; 2006 Nov; 98(11):667-78. PubMed ID: 17042742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular basis for the polyamine-ompF porin interactions: inhibitor and mutant studies.
    Iyer R; Wu Z; Woster PM; Delcour AH
    J Mol Biol; 2000 Apr; 297(4):933-45. PubMed ID: 10736228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Staphylococcal pore-forming toxins.
    Prévost G; Mourey L; Colin DA; Menestrina G
    Curr Top Microbiol Immunol; 2001; 257():53-83. PubMed ID: 11417122
    [No Abstract]   [Full Text] [Related]  

  • 14. The Importance of Therapeutically Targeting the Binary Toxin from
    Abeyawardhane DL; Godoy-Ruiz R; Adipietro KA; Varney KM; Rustandi RR; Pozharski E; Weber DJ
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33805767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pore-forming Esx proteins mediate toxin secretion by Mycobacterium tuberculosis.
    Tak U; Dokland T; Niederweis M
    Nat Commun; 2021 Jan; 12(1):394. PubMed ID: 33452244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toward a structural understanding of Clostridium difficile toxins A and B.
    Pruitt RN; Lacy DB
    Front Cell Infect Microbiol; 2012; 2():28. PubMed ID: 22919620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective inhibition of binding of Bacillus thuringiensis Cry1Ab toxin to cadherin-like and aminopeptidase proteins in brush-border membranes and dissociated epithelial cells from Bombyx mori.
    Ibiza-Palacios MS; Ferré J; Higurashi S; Miyamoto K; Sato R; Escriche B
    Biochem J; 2008 Jan; 409(1):215-21. PubMed ID: 17725543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [VapC toxin inhibition as a method for prevention of the formation of resting forms of mycobacteria].
    Demidenok OI; Shumkov MS; Goncharenko AV
    Prikl Biokhim Mikrobiol; 2016; 52(6):579-83. PubMed ID: 29513477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Restoration of pore-forming activity in staphylococcal alpha-hemolysin by targeted covalent modification.
    Walker B; Bayley H
    Protein Eng; 1995 May; 8(5):491-5. PubMed ID: 8532671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of molecular properties of pore-forming toxins with planar lipid bilayers.
    Dalla Serra M; Menestrina G
    Methods Mol Biol; 2000; 145():171-88. PubMed ID: 10820722
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 38.